Clinical Trial Update: Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety, pharmacokinetics, and efficacy of a Bepotastine Besilate nasal product after ragweed pollen exposure in seasonal all…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Bepotastine Besilate nasal product (bepotastine besilate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Seasonal Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-09-14